[1]
|
Ruiz-Ortega, M., Rayego-Mateos, S., Lamas, S., et al. (2020) Targeting the Progression of Chronic Kidney Disease. Nature Reviews Nephrology, 16, 269-288. https://doi.org/10.1038/s41581-019-0248-y
|
[2]
|
Carney, E.F. (2020) The Impact of Chronic Kidney Disease on Global Health. Nature Reviews Nephrology, 16, 251.
https://doi.org/10.1038/s41581-020-0268-7
|
[3]
|
Ahmadmehrabi, S. and Tang, W.H.W. (2018) Hemodialy-sis-Induced Cardiovascular Disease. Seminars in Dialysis, 31, 258-267. https://doi.org/10.1111/sdi.12694
|
[4]
|
Xie, T., Chen, C., Peng, Z., et al. (2020) Erythrocyte Metabolic Reprogramming by Sphingosine 1-Phosphate in Chronic Kidney Disease and Therapies. Circulation Research, 127, 360-375.
https://doi.org/10.1161/CIRCRESAHA.119.316298
|
[5]
|
Dai, L., Golembiewska, E., Lindholm, B., et al. (2017) End-Stage Renal Disease, Inflammation and Cardiovascular Outcomes. Contributions to Nephrology, 191, 32-43. https://doi.org/10.1159/000479254
|
[6]
|
Wang, Y. and Gao, L. (2022) Inflammation and Cardiovascular Disease Associated with Hemodialysis for End-Stage Renal Disease. Frontiers in Pharmacology, 13, Article ID: 800950. https://doi.org/10.3389/fphar.2022.800950
|
[7]
|
Vázquez-Victorio, G., González-Espinosa, C., Espinosa-Riquer, Z.P., et al. (2016) GPCRs and Actin-Cytoskeleton Dynamics. Methods in Cell Biology, 132, 165-188. https://doi.org/10.1016/bs.mcb.2015.10.003
|
[8]
|
Li, F., Wang, J., Zhu, Y., et al. (2018) SphK1/S1P Mediates PDGF-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation via miR-21/BMPRII/Id1 Signaling Pathway. Cel-lular Physiology and Biochemistry, 51, 487-500.
https://doi.org/10.1159/000495243
|
[9]
|
Bazzazi, H. and Popel, A.S. (2017) Computational Investigation of Sphin-gosine Kinase 1 (SphK1) and Calcium Dependent ERK1/2 Activation Downstream of VEGFR2 in Endothelial Cells. PLOS Computational Biology, 13, e1005332. https://doi.org/10.1371/journal.pcbi.1005332
|
[10]
|
Zhou, F., Wang, Y.K., Zhang, C.G., et al. (2021) miR-19a/b-3p Promotes Inflammation during Cerebral Ischemia/Reperfusion Injury via SIRT1/FoxO3/SPHK1 Pathway. Journal of Neuroinflammation, 18, Article No. 122.
https://doi.org/10.1186/s12974-021-02172-5
|
[11]
|
Lau, P., Zhang, G., Zhao, S., et al. (2022) Sphingosine Kinase 1 Promotes Tumor Immune Evasion by Regulating the MTA3-PD-L1 Axis. Cellular & Molecular Immunology, 19, 1153-1167. https://doi.org/10.1038/s41423-022-00911-z
|
[12]
|
Liu, K., Sun, T., Luan, Y., et al. (2022) Berberine Ameliorates Erectile Dysfunction in Rats with Streptozotocin-Induced Diabetes Mellitus through the Attenuation of Apoptosis by Inhibiting the SPHK1/S1P/S1PR2 and MAPK Pathways. Andrology, 10, 404-418. https://doi.org/10.1111/andr.13119
|
[13]
|
Nathan, C. and Ding, A. (2010) Nonresolving Inflammation. Cell, 140, 871-882.
https://doi.org/10.1016/j.cell.2010.02.029
|
[14]
|
Medzhitov, R. (2008) Origin and Physiological Roles of Inflamma-tion. Nature, 454, 428-435.
https://doi.org/10.1038/nature07201
|
[15]
|
Filiopoulos, V., Hadjiyannakos, D., Takouli, L., et al. (2009) Inflamma-tion and Oxidative Stress in End-Stage Renal Disease Patients Treated with Hemodialysis or Peritoneal Dialysis. The In-ternational Journal of Artificial Organs, 32, 872-882. https://doi.org/10.1177/039139880903201206
|
[16]
|
Jankowska, M., Cobo, G., Lindholm, B., et al. (2017) Inflam-mation and Protein-Energy Wasting in the Uremic Milieu. Contributions to Nephrology, 191, 58-71. https://doi.org/10.1159/000479256
|
[17]
|
Wu, J., Guo, N., Chen, X., et al. (2020) Coexistence of Mi-cro-Inflammatory and Macrophage Phenotype Abnormalities in Chronic Kidney Disease. International Journal of Clini-cal and Experimental Pathology, 13, 317-323.
|
[18]
|
Friedrich, B., Alexander, D., Janessa, A., et al. (2006) Acute Effects of Hemodialysis on Cytokine Transcription Profiles: Evidence for C-Reactive Protein-Dependency of Mediator Induction. Kidney International, 70, 2124-2130.
https://doi.org/10.1038/sj.ki.5001865
|
[19]
|
Ademowo, O.S., Sharma, P., Cockwell, P., et al. (2020) Distribution of Plasma Oxidised Phosphatidylcholines in Chronic Kidney Disease and Periodontitis as a Co-Morbidity. Free Radical Bi-ology and Medicine, 146, 130-138.
https://doi.org/10.1016/j.freeradbiomed.2019.10.012
|
[20]
|
Wu, W., Yang, J.J., Yang, H.M., et al. (2017) Mul-ti-Glycoside of Tripterygium wilfordii Hook. f. Attenuates Glomerulosclerosis in a Rat Model of Diabetic Nephropathy by Exerting Anti-Microinflammatory Effects without Affecting Hyperglycemia. International Journal of Molecular Medicine, 40, 721-730. https://doi.org/10.3892/ijmm.2017.3068
|
[21]
|
Kooman, J.P., Dekker, M.J., Usvyat, L.A., et al. (2017) Inflammation and Premature Aging in Advanced Chronic Kidney Disease. American Journal of Physiolo-gy-Renal Physiology, 313, F938-f950.
https://doi.org/10.1152/ajprenal.00256.2017
|
[22]
|
Ebert, T., Pawelzik, S.C., Witasp, A., et al. (2020) Inflammation and Premature Ageing in Chronic Kidney Disease. Toxins (Basel), 12, Article No. 227. https://doi.org/10.3390/toxins12040227
|
[23]
|
Carracedo, M., Artiach, G., Witasp, A., et al. (2019) The G-Protein Coupled Receptor ChemR23 Determines Smooth Muscle Cell Phenotypic Switching to Enhance High Phos-phate-Induced Vascular Calcification. Cardiovascular Research, 115, 1557-1566. https://doi.org/10.1093/cvr/cvy316
|
[24]
|
Kooman, J.P., Kotanko, P., Schols, A.M., et al. (2014) Chronic Kidney Disease and Premature Ageing. Nature Reviews Nephrology, 10, 732-742. https://doi.org/10.1038/nrneph.2014.185
|
[25]
|
Mikolajczyk, T.P. and Guzik, T.J. (2019) Adaptive Immunity in Hy-pertension. Current Hypertension Reports, 21, Article No. 68. https://doi.org/10.1007/s11906-019-0971-6
|
[26]
|
Pedruzzi, L.M., Cardozo, L.F., Daleprane, J.B., et al. (2015) Sys-temic Inflammation and Oxidative Stress in Hemodialysis Patients Are Associated with Down-Regulation of Nrf2. Journal of Nephrology, 28, 495-501.
https://doi.org/10.1007/s40620-014-0162-0
|
[27]
|
Stinghen, A.E.M., Massy, Z.A., Vlassara, H., et al. (2016) Ure-mic Toxicity of Advanced Glycation End Products in CKD. Journal of the American Society of Nephrology, 27, 354-370. https://doi.org/10.1681/ASN.2014101047
|
[28]
|
Sanajou, D., Ghorbani Haghjo, A., Argani, H., et al. (2018) AGE-RAGE Axis Blockade in Diabetic Nephropathy: Current Status and Future Directions. European Journal of Pharmacology, 833, 158-164.
https://doi.org/10.1016/j.ejphar.2018.06.001
|
[29]
|
Yunna, C., Mengru, H., Lei, W., et al. (2020) Macrophage M1/M2 Polarization. European Journal of Pharmacology, 877, Article ID: 173090. https://doi.org/10.1016/j.ejphar.2020.173090
|
[30]
|
Xu, N., Bo, Q., Shao, R., et al. (2019) Chitinase-3-Like-1 Pro-motes M2 Macrophage Differentiation and Induces Choroidal Neovascularization in Neovascular Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science, 60, 4596-4605. https://doi.org/10.1167/iovs.19-27493
|
[31]
|
Wilson, M.S. and Wynn, T.A. (2009) Pulmonary Fibrosis: Pathogene-sis, Etiology and Regulation. Mucosal Immunology, 2, 103-121. https://doi.org/10.1038/mi.2008.85
|
[32]
|
Nathan, C. (2022) Nonresolving Inflammation Redux. Immunity, 55, 592-605.
https://doi.org/10.1016/j.immuni.2022.03.016
|
[33]
|
Jing, H., Tang, S., Lin, S., et al. (2020) Adiponectin in Renal Fibrosis. Aging (Albany NY), 12, 4660-4672.
https://doi.org/10.18632/aging.102811
|
[34]
|
Campanholle, G., Ligresti, G., Gharib, S.A., et al. (2013) Cellular Mechanisms of Tissue Fibrosis. 3. Novel Mechanisms of Kidney Fibrosis. American Journal of Physiology-Cell Physi-ology, 304, C591-C603.
https://doi.org/10.1152/ajpcell.00414.2012
|
[35]
|
Li, R., Guo, Y., Zhang, Y., et al. (2019) Salidroside Ameliorates Renal Interstitial Fibrosis by Inhibiting the TLR4/NF-κB and MAPK Signaling Pathways. International Journal of Mo-lecular Sciences, 20, 1103.
https://doi.org/10.3390/ijms20051103
|
[36]
|
Baker, D.A., Barth, J., Chang, R., et al. (2010) Genetic Sphingosine Kinase 1 Deficiency Significantly Decreases Synovial Inflammation and Joint Erosions in Murine TNF-Alpha-Induced Arthritis. The Journal of Immunology, 185, 2570-2579. https://doi.org/10.4049/jimmunol.1000644
|
[37]
|
Ding, N., Meng, Y., Liu, L., et al. (2022) Sphingosine Kinase-1 (SPHK1) Promotes Inflammation in Infantile Pneumonia by Reg-ulating NLRP3 Inflammasome and SIRT1 Expression. Histology and Histopathology, 37, 1227-1240.
|
[38]
|
Hou, L., Yang, L., Chang, N., et al. (2020) Macrophage Sphingosine 1-Phosphate Receptor 2 Blockade Attenuates Liver Inflam-mation and Fibrogenesis Triggered by NLRP3 Inflammasome. Frontiers in Immunology, 11, Article No. 1149. https://doi.org/10.3389/fimmu.2020.01149
|
[39]
|
Wu, X., Xu, J., Li, X., et al. (2022) Inhibition of SphK1/S1P Sig-naling Pathway Alleviates Fibrosis and Inflammation of Rat Myocardium after Myocardial Infarction. Computational and Mathematical Methods in Medicine, 2022, Article ID: 5985375. https://doi.org/10.1155/2022/5985375
|
[40]
|
Chen, L., Li, L., Song, Y., et al. (2021) Blocking SphK1/S1P/S1PR1 Signaling Pathway Alleviates Lung Injury Caused by Sepsis in Acute Ethanol Intoxication Mice. Inflammation, 44, 2170-2179.
https://doi.org/10.1007/s10753-021-01490-3
|
[41]
|
Qu, L., Shi, K., Xu, J., et al. (2022) Atractylenolide-1 Targets SPHK1 and B4GALT2 to Regulate Intestinal Metabolism and Flora Composition to Improve Inflammation in Mice with Colitis. Phytomedicine, 98, Article ID: 153945.
https://doi.org/10.1016/j.phymed.2022.153945
|